Oxford GlycoSystems Ltd. said it has completed an $8 millionround of venture financing that will fund its expanded R&Defforts and the introduction of new instrumentation.
The round, which was led by S.R. One, included Suez Ventures;Singapore EDB; Kleiner, Perkins, Caufield & Byers; and OxfordUniversity.
OGS of Abingdon, United Kingdom, is switching its productfocus to instrumentation for molecular biology and molecularstructure studies, particularly carbohydrates.
Within the next six months, OGS will introduce its GlycoPrep1000 for release and purification of carbohydrates fromglycoconjugates. The company will continue to provide acarbohydrate analysis service and supply complexcarbohydrates and analogues.
Prior to this financing round, OGS had raised $8 million (4.6million pounds) in equity financing since its founding in 1988to commercialize technology developed at Oxford University.
(c) 1997 American Health Consultants. All rights reserved.